Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

The Lancet Oncology - Tập 8 - Trang 226-234 - 2007
Val Gebski1, Bryan Burmeister2, B Mark Smithers2, Kerwyn Foo1, John Zalcberg3, John Simes1
1National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
2University of Queensland, Princess Alexandra Hospital, Brisbane, Australia
3Peter MacCallum Cancer Centre, Melbourne, Australia

Thông tin
Thông tin xuất bản

The Lancet Oncology

Tập 8

226-234

Thông tin tác giả